P

Inventor

WANG WEIYI

CN81 patents
⚠️ This page may combine multiple inventors who share the name “WANG WEIYI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HANGZHOU GREAT STAR IND CO LTD

17 patents

HANGZHOU GREAT STAR TOOLS CO LTD

14 patents

MEMORIAL SLOAN KETTERING CANCER CENTER

11 patents
US10736962B2Aug 11, 2020

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER15 citations94
US10548930B2Feb 4, 2020

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER15 citations93
US10512662B2Dec 24, 2019

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER6 citations84
US10639366B2May 5, 2020

Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER10 citations83
US10176292B2Jan 8, 2019

STING crystals and modulators

MEMORIAL SLOAN KETTERING CANCER CENTER7 citations82
US12036279B2Jul 16, 2024

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations73
US11986503B2May 21, 2024

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations73
US11541087B2Jan 3, 2023

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations73
US11285209B2Mar 29, 2022

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER3 citations73
US10765711B2Sep 8, 2020

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations73
US11253560B2Feb 22, 2022

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

MEMORIAL SLOAN KETTERING CANCER CENTER3 citations72

HANGZHOU UNITED TOOLS CO LTD

3 patents

WANG WEIYI

3 patents

UNIV YALE

1 patent

HANGZHOU GREATSTAR INTELLIGENT TECH CO LTD

1 patent

Showing the top 50 of 81 patents by PatentIndex Score.